Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00683423 · ClinicalTrials.gov registry record · Phase 2

BMS-741672 for Diabetic Neuropathic Pain

A Phase 2 study of Neuropathic Pain, sponsored by Bristol-Myers Squibb.

Completed
Registry status
Phase 2
Development phase
50
Enrollment target
8
Study locations

NCT00683423 is a Phase 2 study of Neuropathic Pain that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 50 participants, below the 100-participant average among 35 other Neuropathic Pain trials with a reported enrollment target (50% lower). The trial reports 8 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00683423, a Phase 2 study of Neuropathic Pain, has completed, sponsored by Bristol-Myers Squibb.

COMPLETED
Registry status
Phase 2
Development phase
50 participants
Enrollment target
8
Study locations

Study Summary

The purpose of the study is to determine whether BMS-741672 improves neuropathic pain in diabetic patients.

Conditions Studied

Neuropathic Pain

Interventions

  • DRUG Placebo
  • DRUG BMS-741672

Study Locations (8)

Florida

  • Palm Beach Neurological Center - Palm Beach Gardens
  • Comprehensive Neurosciences, Inc. - St. Petersburg

California

  • University Clinical Investigators, Inc. - Tustin

Illinois

  • The Pain & Rehabilitation Clinic Of Chicago - Chicago

Nevada

  • Advanced Biomedical Research Of America - Las Vegas

North Carolina

  • Physicians East P.A. - Greenville

Ohio

  • Neurology Center Of Ohio - Toledo

Texas

  • Research Institute Of Dallas, P.A. - Dallas

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2008-07
Est. Completion 2009-02
Phase Phase 2

Sponsor

Bristol-Myers Squibb

1,025 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00683423

The ClinicalTrials.gov registry entry for NCT00683423 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 100-participant average among 35 other Neuropathic Pain trials with a reported enrollment target (50% lower). The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Neuropathic Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00683423 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Florida, California, Illinois.

Frequently Asked Questions

What is clinical trial NCT00683423 about?

NCT00683423 is a clinical study titled "BMS-741672 for Diabetic Neuropathic Pain". The purpose of the study is to determine whether BMS-741672 improves neuropathic pain in diabetic patients.

What is the current status of trial NCT00683423?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2008-07. Estimated completion is 2009-02.

What conditions does trial NCT00683423 study?

This clinical trial studies the following conditions: Neuropathic Pain.

What interventions are being tested in trial NCT00683423?

The interventions under investigation include: Placebo (DRUG), BMS-741672 (DRUG).

Who is sponsoring clinical trial NCT00683423?

This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00683423 being conducted?

This trial has 8 study locations across California, Florida, Illinois, Nevada, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Neuropathic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Neuropathic Pain

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.